Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism
暂无分享，去创建一个
T. Nafee | C. Gibson | M. Kerneis | R. Travis | M. Yee | S. H. Kazmi | S. Datta | G. Chi | Sadaf Sharfaei | Ahmed Elsaiey | F. Alkhalfan | M. Mir | A. Kalaycı | M. Jafarizade | A. Ganti | E. Ghaffarpasand | Anmol Pitliya | M. Alihashemi | Iqra Qamar | Mohamadmostafa Jahansouz | U. Talib | Farima Kahe | S. Habibi | M. Abdelwahed | Feham Tariq | Manpreet Kaur | A. Younes | S. Walia | Amandeep Singh | Syed Muhammad Dildar | M. Afzal | A. Elsaiey | A. Kalayci | Fahad Alkhalfan | Mahshid Mir | C. M. Gibson | Eiman Ghaffarpasand | Tarek Nafee | Syed Muhammad Dildar | M. Khurram Afzal